Modernizing the Human Subjects Regulations
Given its importance in scientific development, human subjects research requires close regulatory attention.
The Institutions for Mental Diseases Exclusion Rule is an Anachronism
The time has come for repealing Medicaid’s Institutions for Mental Diseases Exclusion rule.
Prescription Drug Affordability
The court ruling striking down the Affordable Care Act may get in the way of making drugs affordable.
Defining and Establishing Goals for Medicare for All
Although “Medicare for all” has picked up political traction, how it will materialize remains unclear.
What Tomorrow Holds for U.S. Health Care
Experts offer solutions to pressing issues in American health care.
Addressing the Constitutionality of Federal Quarantine Rules
Scholars say constitutionally shaky infectious disease regulations must yield to better prevention programs.
Should the Federal Government Allow States to Require Medicaid Recipients to Work?
A federal judge strikes a blow to two states’ Medicaid work requirements.
Determining How to Regulate Encapsulated Placenta
Scholar argues that FDA should use a narrowly tailored framework to regulate encapsulated placenta pills.
Got Soy Beverage?
Plant-based milk producers may soon no longer be able to put “milk” on their labels.
The Case for Eating Bugs
Scholar argues FDA should regulate insects as food to help address food insecurity.
Judge Suspends Rules Expanding Exemptions to the Contraceptive Mandate
National injunction stops corporations from claiming religious or moral exemptions to birth control coverage.
How FDA Drug Review Contributed to the Opioid Epidemic
Scholars argue that FDA should use larger health data sets in its approval process for high-risk drugs.